A recent study published in the New England Journal of Medicine found that the use of the drug Trasylol, a drug commonly used to help reduce the loss of blood during major surgeries like open heart surgery and spinal surgery, has been found to dramatically increase the risk of kidney failure, heart attacks, heart failure and strokes.
Trasylol is made by Bayer. Additionally, two generic drugs, aminocaproic acid and tranexamic acid, were just as effective, safer and dramatically less expensive. Dennis Mangano, Ph.D., M.D., the lead author, noted that the life-threatening side effects from the use of Trasylol occurred more frequently than those seen with Vioxx. His conclusions showed there was a doubling of the risk of kidney failure requiring dialysis, a 48% increased risk of heart attack, 109% increased risk of heart failure, and a 181% increased risk of stroke or encephalopathy. Neither aminocaproic acid or tranexamic acid was associated with these increased risks. The authors felt that using the alternative, safer drugs would prevent kidney failure in 11,50 patients per year world-wide, saving $1 Billion in dialysis costs and $250 million in direct patient care costs.
If you or a loved one received Trasylol and had a serious complication like kidney failure, heart attack, heart failure or stroke, please Contact Us.